Seminars in Hematology
Volume 45 , Pages S7-S11 , April 2008

Further Understanding of Recombinant Activated Factor VII Mode of Action

  • Dougald M. Monroe

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dougald M. Monroe, PhD, Division of Hematology/Oncology, 932 Mary Ellen Jones Building, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7035.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Dougald Monroe has a University of North Carolina-administered research grant funded by Novo Nordisk. He has also received honoraria from Novo Nordisk for speaking at meetings.

PII: S0037-1963(08)00053-X

doi: 10.1053/j.seminhematol.2008.03.013

Seminars in Hematology
Volume 45 , Pages S7-S11 , April 2008

Article Tools

* Image Usage & Resolution